Cole Pinnow, Chief Commercial Officer at Cogent Biosciences, Inc. (COGT), bought 43,750 shares at $7.60 ($333K) on 2025-01-14, disclosed to the SEC on 2025-01-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.